US 8652776
Prediction of QT prolongation based on SNP genotype
granted A61PA61P25/18A61P25/20
Quick answer
US patent 8652776 (Prediction of QT prolongation based on SNP genotype) held by VANDA PHARMACEUTICALS INC. expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VANDA PHARMACEUTICALS INC.
- Grant date
- Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61P, A61P25/18, A61P25/20, A61P25/24, A61P9/06